Full Text View
Tabular View
No Study Results Posted
Related Studies
Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure
This study has been completed.
Study NCT00729222   Information provided by Merck

First Received on August 5, 2008.   Last Updated on May 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
Comparator: Placebo
rolofylline
Additional drug interventions recognized in this trial
1,3-dipropyl-8-(3-noradamantyl)xanthine
More general drug interventions related to this trial
Cardiovascular Agents
Diuretics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Merck
NovaCardia, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services